To be used for tenders as needed.
Download Print Ready Version: enVast Brochure | Download Digital Version: High Resolution enVast Brochure Product brochure to be used as leave behind piece as needed. Please follow ENVAST BRANDING GUIDELINES if local adaptation is needed.
PDF to download and share with print media. No changes are allowed.
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round.
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke.
As a board observer and senior advisor to the company, Earl Slee brings extensive medical device innovation and business development expertise.
As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the medical device start-up space.
Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI
Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.
VESALIO BASIC TRAINING Module 6: COMPETITION & SELLING
VESALIO BASIC TRAINING Module 5: NeVa